SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-015510
Filing Date
2021-11-10
Accepted
2021-11-10 16:25:25
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20211110x8k.htm   iXBRL 8-K 36229
2 EX-99.1 gbio-20211110xex99d1.htm EX-99.1 64232
3 GRAPHIC gbio-20211110xex99d1001.jpg GRAPHIC 5418
  Complete submission text file 0001558370-21-015510.txt   233673

Data Files

Seq Description Document Type Size
4 EX-101.SCH gbio-20211110.xsd EX-101.SCH 2821
5 EX-101.LAB gbio-20211110_lab.xml EX-101.LAB 13139
6 EX-101.PRE gbio-20211110_pre.xml EX-101.PRE 11157
7 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20211110x8k_htm.xml XML 4897
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 211397053
SIC: 2834 Pharmaceutical Preparations